GIP
GILD icon

Greatmark Investment Partners’s Gilead Sciences GILD Stock Holding History

Greatmark Investment Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.58M Sell
28,312
-378
-1% -$49.8K 0.39% 49
2026
Q1 		$4M Sell
28,690
-510
-2% -$71.4K 0.47% 43
2025
Q4 		$3.58M Buy
29,200
+83
+0.3% +$10.1K 0.42% 48
2025
Q3 		$3.23M Sell
29,117
-1,290
-4% -$147K 0.39% 47
2025
Q2 		$3.37M Sell
30,407
-2,535
-8% -$270K 0.42% 47
2025
Q1 		$3.69M Sell
32,942
-90
-0.3% -$9.29K 0.5% 45
2024
Q4 		$3.05M Buy
33,032
+620
+2% +$55.8K 0.42% 50
2024
Q3 		$2.72M Buy
32,412
+1,735
+6% +$132K 0.37% 51
2024
Q2 		$2.1M Sell
30,677
-65
-0.2% -$4.34K 0.31% 54
2024
Q1 		$2.25M Buy
30,742
+970
+3% +$74.6K 0.32% 55
2023
Q4 		$2.41M Buy
29,772
+31
+0.1% +$2.41K 0.38% 52
2023
Q3 		$2.23M Buy
29,741
+2,325
+8% +$179K 0.39% 53
2023
Q2 		$2.11M Sell
27,416
-979
-3% -$78.1K 0.36% 53
2023
Q1 		$2.36M Sell
28,395
-436
-2% -$36.1K 0.42% 48
2022
Q4 		$2.48M Buy
28,831
+5
+0% +$396 0.45% 49
2022
Q3 		$1.78M Sell
28,826
-240
-0.8% -$15.1K 0.34% 52
2022
Q2 		$1.8M Buy
29,066
+3,375
+13% +$209K 0.34% 52
2022
Q1 		$1.53M Sell
25,691
-2,230
-8% -$143K 0.25% 61
2021
Q4 		$2.03M Sell
27,921
-3,875
-12% -$267K 0.34% 53
2021
Q3 		$2.22M Buy
31,796
+2,105
+7% +$148K 0.42% 47
2021
Q2 		$2.04M Sell
29,691
-33,713
-53% -$2.25M 0.37% 53
2021
Q1 		$4.1M Sell
63,404
-7,344
-10% -$474K 0.8% 31
2020
Q4 		$4.12M Sell
70,748
-23,775
-25% -$1.43M 0.89% 31
2020
Q3 		$5.97M Sell
94,523
-1,280
-1% -$88.8K 1.5% 21
2020
Q2 		$7.37M Sell
95,803
-4,288
-4% -$329K 1.94% 18
2020
Q1 		$7.48M Sell
100,091
-4,995
-5% -$345K 2.4% 15
2019
Q4 		$6.83M Sell
105,086
-10,481
-9% -$683K 1.69% 22
2019
Q3 		$7.33M Sell
115,567
-1,143
-1% -$74.7K 2.01% 19
2019
Q2 		$7.88M Buy
116,710
+6,024
+5% +$396K 2.35% 14
2019
Q1 		$7.2M Buy
110,686
+15,430
+16% +$1.03M 2.27% 15
2018
Q4 		$5.96M Buy
95,256
+1,970
+2% +$138K 2.13% 17
2018
Q3 		$7.2M Buy
93,286
+5,263
+6% +$397K 2.27% 15
2018
Q2 		$6.24M Buy
88,023
+3,608
+4% +$255K 2.15% 16
2018
Q1 		$6.36M Buy
84,415
+7,111
+9% +$565K 2.32% 14
2017
Q4 		$5.54M Buy
77,304
+2,009
+3% +$153K 2.01% 16
2017
Q3 		$6.1M Buy
75,295
+9,135
+14% +$699K 2.33% 15
2017
Q2 		$4.68M Buy
66,160
+7,750
+13% +$516K 1.88% 19
2017
Q1 		$3.97M Buy
58,410
+7,845
+16% +$552K 1.63% 21
2016
Q4 		$3.62M Buy
50,565
+14,015
+38% +$1.04M 1.52% 22
2016
Q3 		$2.89M Buy
36,550
+2,565
+8% +$208K 1.26% 25
2016
Q2 		$2.83M Buy
+33,985
New +$3.02M 1.27% 26

Other funds holding GILD

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Greatmark Investment Partners's GILD Position: Q2 2026 in Review

Greatmark Investment Partners reduced its Gilead Sciences (GILD) stake by 1.3% in Q2 2026, selling an estimated $49.8K and leaving 28,312 shares worth $3.58M. The position accounts for 0.39% of the portfolio, ranked #49.

Greatmark Investment Partners first reported a position in GILD in Q2 2016 and has held it in 41 quarters since. The position peaked at $7.88M in Q2 2019. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Greatmark Investment Partners held 28,312 shares of Gilead Sciences worth $3.58M as of Q2 2026.
  • Greatmark Investment Partners sold 378 Gilead Sciences shares in Q2 2026, an estimated $49.8K.
  • Gilead Sciences made up 0.39% of Greatmark Investment Partners's portfolio in Q2 2026, its #49 holding.
  • Greatmark Investment Partners first reported a position in Gilead Sciences in Q2 2016 and has held it in 41 quarters since.
  • Greatmark Investment Partners's Gilead Sciences position peaked at $7.88M in Q2 2019.
  • 690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Greatmark Investment Partners's 13F filing for Q2 2026, filed 24 Jul 2026.